VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma.
EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinoma.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinoma.
EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinoma. J Natl Cancer Inst. 2009 Sep 02; 101(17):1193-205.
View in:
PubMed
subject areas
Animals
Antibodies, Monoclonal
Antineoplastic Agents
Apoptosis
Blotting, Western
Cell Line, Tumor
Cell Survival
Female
Fluorescent Antibody Technique
Humans
Immunoconjugates
Immunohistochemistry
In Situ Nick-End Labeling
Mice
Oligopeptides
Ovarian Neoplasms
Platelet Endothelial Cell Adhesion Molecule-1
Proliferating Cell Nuclear Antigen
Receptor, EphA2
Xenograft Model Antitumor Assays
authors with profiles
ROSEMARIE SCHMANDT
ANIL K SOOD
LINGEGOWDA SELANERE MANGALA
MARK SEUNGWOOK KIM
ROBERT COLEMAN